DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Neoral (Cyclosporine) - Disability - Suspected Cause - Side Effect Reports

 
 



Index of reports > Disability (24)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Neoral (Cyclosporine) disability. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Neoral side effects in 41 year old male

Reported by a physician from France on 2012-08-23

Patient: 41 year old male

Reactions: Optic Neuritis

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Coly-Mycin S Ophthalmic Drops
    Indication: Cystic Fibrosis
    Start date: 2007-09-25

Creon
    Administration route: Oral
    Indication: Pancreatic Insufficiency
    Start date: 2007-09-25

Keppra
    Administration route: Oral
    Indication: Epilepsy
    Start date: 2007-07-30

Lovenox
    Indication: Product Used FOR Unknown Indication
    Start date: 2007-09-25

Moviprep
    Administration route: Oral
    Indication: Constipation
    Start date: 2007-09-25

Neoral
    Administration route: Oral
    Indication: Lung Transplant
    End date: 2007-10-02

Nexium
    Administration route: Oral
    Indication: Prophylaxis Against Gastrointestinal Ulcer
    Start date: 2007-09-25

Oxacillin
    Administration route: Oral
    Indication: Staphylococcal Infection
    Start date: 2007-09-19
    End date: 2007-11-07

Prednisolone
    Administration route: Oral
    Indication: Lung Transplant
    Start date: 2007-09-24

Valganciclovir
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2007-09-24
    End date: 2007-11-05

Other drugs received by patient: Paroxetine HCL; Atarax; Zolpidem



Possible Neoral side effects in male

Reported by a physician from France on 2012-08-17

Patient: male

Reactions: Optic Neuritis

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Coly-Mycin S Ophthalmic Drops
    Indication: Cystic Fibrosis
    Start date: 2007-09-25

Creon
    Administration route: Oral
    Indication: Pancreatic Insufficiency
    Start date: 2007-09-25

Keppra
    Administration route: Oral
    Indication: Convulsion
    Start date: 2007-07-30

Lovenox
    Start date: 2007-09-25

Moviprep
    Administration route: Oral
    Indication: Constipation
    Start date: 2007-09-25

Neoral
    Administration route: Oral
    Indication: Lung Transplant
    Start date: 2007-07-01
    End date: 2007-10-02

Nexium
    Administration route: Oral
    Indication: Prophylaxis Against Gastrointestinal Ulcer
    Start date: 2007-09-25

Oxacillin
    Administration route: Oral
    Indication: Staphylococcal Infection
    Start date: 2007-09-19
    End date: 2007-11-07

Prednisolone
    Administration route: Oral
    Indication: Lung Transplant
    Start date: 2007-09-24

Valganciclovir
    Administration route: Oral
    Start date: 2007-09-24
    End date: 2007-11-05

Other drugs received by patient: Paroxetine HCL; Atarax; Zolpidem Tartrate



Possible Neoral side effects in male

Reported by a health professional (non-physician/pharmacist) from France on 2012-08-14

Patient: male

Reactions: White Blood Cell Count Decreased, Visual Impairment, Optic Ischaemic Neuropathy, Papilloedema

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Colistin Sulfate
    Dosage: 1 df, bid
    Indication: Cystic Fibrosis Pancreatic
    Start date: 2007-09-25

Creon
    Dosage: 1 df, 5qd
    Administration route: Oral
    Indication: Pancreatic Insufficiency
    Start date: 2007-09-25

Keppra
    Dosage: 1 df, bid
    Administration route: Oral
    Indication: Epilepsy
    Start date: 2007-07-30

Lovenox
    Dosage: 0.2 ml, daily
    Start date: 2007-09-25

Moviprep
    Dosage: 1 df, tid
    Administration route: Oral
    Indication: Constipation
    Start date: 2007-09-25

Neoral
    Dosage: 325 mg in the morning and 310 mg in th evening
    Administration route: Oral
    Start date: 2007-10-01
    End date: 2007-10-02

Neoral
    Administration route: Oral
    Indication: Lung Transplant
    Start date: 2007-07-01

Nexium
    Dosage: 40 mg, qd
    Administration route: Oral
    Indication: Prophylaxis Against Gastrointestinal Ulcer
    Start date: 2007-09-25

Oxacillin
    Dosage: 1 g, tid
    Administration route: Oral
    Indication: Staphylococcal Infection
    Start date: 2007-09-19
    End date: 2007-11-07

Prednisolone
    Dosage: 20 mg, qd
    Administration route: Oral
    Indication: Lung Transplant
    Start date: 2007-09-24

Valganciclovir
    Dosage: 1 df, bid
    Administration route: Oral
    Start date: 2007-09-24
    End date: 2007-11-05

Other drugs received by patient: Zolpidem Tartrate; Atarax; Paroxetine HCL



Possible Neoral side effects in 41 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-08-14

Patient: 41 year old male

Reactions: Optic Ischaemic Neuropathy

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Colimycine
    Dosage: 2 units daily
    Indication: Cystic Fibrosis
    Start date: 2007-09-25

Creon
    Dosage: 5 units daily
    Administration route: Oral
    Indication: Pancreatic Insufficiency
    Start date: 2007-09-25

Keppra
    Dosage: daily dose: 2 units
    Administration route: Oral
    Indication: Convulsion
    Start date: 2007-07-30

Lovenox
    Dosage: daily dose: 0.2 ml
    Start date: 2007-09-25

Moviprep
    Dosage: 3 units daily, as necessary
    Administration route: Oral
    Indication: Constipation
    Start date: 2007-09-25

Neoral
    Dosage: on 01-oct-2007: 352 mg in morning, 310 mg in evening
    Administration route: Oral
    Indication: Lung Transplant
    Start date: 2007-07-01
    End date: 2007-10-02

Nexium
    Dosage: daily dose: 40 mg
    Administration route: Oral
    Indication: Prophylaxis Against Gastrointestinal Ulcer
    Start date: 2007-09-25

Oxacillin
    Dosage: daily dose: 3 grams
    Administration route: Oral
    Indication: Staphylococcal Infection
    Start date: 2007-09-19
    End date: 2007-11-07

Prednisolone
    Dosage: daily dose: 20 mg
    Administration route: Oral
    Indication: Lung Transplant
    Start date: 2007-09-24

Valganciclovir
    Dosage: 2 units daily
    Administration route: Oral
    Start date: 2007-09-24
    End date: 2007-11-05

Other drugs received by patient: Zolpidem Tartrate; Paroxetine HCL; Atarax; Mycophenolate Mofetil



Possible Neoral side effects in 60 year old male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-31

Patient: 60 year old male

Reactions: Neurotoxicity, CSF Protein Increased, Central Nervous System Lesion, Muscular Weakness, Toxicity To Various Agents, Hypoaesthesia, Hemiplegia

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Neoral



Possible Neoral side effects in 60 year old male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-31

Patient: 60 year old male

Reactions: Neurotoxicity, CSF Protein Increased, Central Nervous System Lesion, Muscular Weakness, Hemiplegia, Hypoaesthesia, Toxicity To Various Agents

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Neoral



Possible Neoral side effects in 45 year old female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-25

Patient: 45 year old female

Reactions: Pulmonary Hypertension, Pulmonary Veno-Occlusive Disease, Hypoxia, Pulmonary Oedema, Respiratory Distress

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Neoral
    Indication: Stem Cell Transplant

Neoral
    Dosage: 240 mg, daily
    Administration route: Oral
    Indication: Prophylaxis Against Graft Versus Host Disease
    Start date: 2011-06-01
    End date: 2011-10-01

Other drugs received by patient: Methotrexate; Cyclophosphamide



Possible Neoral side effects in female

Reported by a physician from Japan on 2012-07-25

Patient: female

Reactions: Pruritus, Melanodermia, Leukoderma, Rash Macular

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Neoral

Other drugs received by patient: Locoid; Ascorbic Acid; Toukishakuyakusan; Ramitect; Protopic; Aleroff; Keishibukuryougan; Fulmeta



Possible Neoral side effects in 45 year old female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-24

Patient: 45 year old female

Reactions: Pulmonary Hypertension, Pulmonary Veno-Occlusive Disease, Hypoxia, Pulmonary Oedema, Respiratory Distress

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Neoral
    Dosage: 240 mg, daily
    Administration route: Oral
    Indication: Prophylaxis Against Graft Versus Host Disease
    Start date: 2011-06-01
    End date: 2011-10-01

Neoral
    Indication: Stem Cell Transplant

Other drugs received by patient: Methotrexate; Cyclophosphamide



Possible Neoral side effects in male

Reported by a physician from Cyprus on 2012-05-11

Patient: male, weighing 175.0 kg (385.0 pounds)

Reactions: Erectile Dysfunction, Ejaculation Delayed

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Neoral



Possible Neoral side effects in female

Reported by a physician from Japan on 2012-05-02

Patient: female

Reactions: Osteoarthritis, Arthralgia

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Neoral



Possible Neoral side effects in 57 year old female

Reported by a physician from Ireland on 2012-04-24

Patient: 57 year old female

Reactions: Dyslipidaemia, Lymphadenopathy, Mouth Ulceration, Dental Plaque, IGA Nephropathy, Headache, Hepatomegaly, Blood Creatinine Increased, Lethargy, Muscle Spasms, Dyspnoea, Pulmonary Sarcoidosis, Toxicity To Various Agents, Nephrotic Syndrome, Tremor, Anxiety, Antinuclear Antibody Positive, Gingival Pain, Joint Swelling, Lymphoma, Asthenia, Normochromic Normocytic Anaemia, Hypertension

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Cyclosporine
    Dosage: 125 mg, 2x/day

Neoral
    Dosage: unk

Neoral
    Dosage: 125mg mane/100mg nocte
    Start date: 2011-04-13

Toviaz
    Dosage: 4 mg, unk
    Administration route: Oral
    Indication: Hypertonic Bladder

Other drugs received by patient: Calcichew-D3; Lansoprazole; Bumetanide; Fosamax; Acetylsalicylic Acid; Ramipril; Ramipril; Amlodipine; Furosemide; Prednisolone; Alendronate Sodium; Lansoprazole; Lercanidipine; Atorvastatin; Prednisolone; Bumetanide



Possible Neoral side effects in 58 year old male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-03-27

Patient: 58 year old male

Reactions: Acute Graft Versus Host Disease, Haemorrhagic Infarction, Encephalitis, Pyrexia, Headache, Hemiparesis, Septic Embolus, Neurologic Neglect Syndrome, Subarachnoid Haemorrhage, Bacterial Sepsis, Depressed Level of Consciousness, Hemiplegia, Bacillus Infection, Meningitis, Engraftment Syndrome

Adverse event resulted in: life threatening event, disablity

Drug(s) suspected as cause:
Neoral

Other drugs received by patient: Fludarabine Phosphate; Irradiation; Busulfan; Corticosteroids; Methotrexate; Solu-Medrol



Possible Neoral side effects in 58 year old male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-03-27

Patient: 58 year old male

Reactions: Acute Graft Versus Host Disease, Haemorrhagic Infarction, Encephalitis, Headache, Hemiparesis, Pyrexia, Septic Embolus, Neurologic Neglect Syndrome, Subarachnoid Haemorrhage, Bacterial Sepsis, Depressed Level of Consciousness, Bacillus Infection, Hemiplegia, Meningitis, Engraftment Syndrome

Adverse event resulted in: life threatening event, disablity

Drug(s) suspected as cause:
Neoral

Other drugs received by patient: Corticosteroids; Fludarabine Phosphate; Methotrexate; Solu-Medrol; Irradiation; Busulfan



Possible Neoral side effects in male

Reported by a physician from Japan on 2012-03-23

Patient: male

Reactions: Dyspnoea, Hepatic Function Abnormal, Liver Disorder, Renal Impairment, Renal Failure, Cardiac Failure, Respiratory Failure, Heart Rate Increased, Oedema Peripheral, Pleural Effusion, Immunosuppressant Drug Level Increased, Renal Tubular Necrosis, Hypertension, Oxygen Saturation Decreased

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Neoral

Other drugs received by patient: Allegra; Candesartan Cilexetil; Tigason



Possible Neoral side effects in female

Reported by a physician from France on 2012-01-05

Patient: female, weighing 50.0 kg (110.0 pounds)

Reactions: Obsessive-Compulsive Disorder, Graft Versus Host Disease, Chills, Tremor, Burning Sensation, Anxiety, Diarrhoea, Disturbance in Attention, Memory Impairment, Hypertension, Blood Creatinine Increased

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Neoral
    Dosage: 100 mg, bid

Neoral
    Dosage: 100 mg, bid (twice per day)
    Indication: Bone Marrow Transplant
    Start date: 2011-06-17

Neoral
    Dosage: 75 mg, bid

Neoral
    Dosage: 50 mg, bid (twice per day)
    Start date: 2011-09-01

Other drugs received by patient: Phenoxymethyl Penicillin; Magnesium; Fluconazole; Prednisone TAB; Valacyclovir Hydrochloride; Speciafoldine; Chlormadinone Acetate TAB; Entocort EC; Bactrim



Possible Neoral side effects in female

Reported by a consumer/non-health professional from France on 2011-12-16

Patient: female, weighing 50.0 kg (110.0 pounds)

Reactions: Obsessive-Compulsive Disorder, Graft Versus Host Disease, Chills, Tremor, Burning Sensation, Anxiety, Diarrhoea, Disturbance in Attention, Memory Impairment, Hypertension, Blood Creatinine Increased

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Neoral
    Dosage: 100 mg, bid
    Indication: Bone Marrow Transplant
    Start date: 2011-06-17

Neoral
    Dosage: 50 mg, bid
    Start date: 2011-09-01

Neoral
    Dosage: 75 mg, bid

Other drugs received by patient: Magnesium; Speciafoldine; Chlormadinone Acetate TAB; Entocort EC; Fluconazole; Phenoxymethyl Penicillin; Valacyclovir Hydrochloride; Bactrim; Prednisone TAB



Possible Neoral side effects in male

Reported by a physician from Japan on 2011-11-11

Patient: male, weighing 68.0 kg (149.6 pounds)

Reactions: Malaise, Central Nervous System Lesion, Vision Blurred, Dizziness, Visual Acuity Reduced, Altered State of Consciousness, Loss of Consciousness, Convulsion

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Neoral
    Dosage: 50 mg, unk
    Administration route: Oral
    Start date: 2011-08-24
    End date: 2011-08-30

Neoral
    Dosage: 125 mg, unk
    Administration route: Oral
    Indication: Glomerulonephritis Membranous
    Start date: 2011-08-03
    End date: 2011-08-15

Prednisolone
    Dosage: 7.5 mg, unk
    Administration route: Oral
    Start date: 2011-10-11

Prednisolone
    Dosage: 35 mg, unk
    Administration route: Oral
    Start date: 2011-08-17
    End date: 2011-08-30

Prednisolone
    Dosage: 45 mg, unk
    Administration route: Oral
    Start date: 2011-08-03

Prednisolone
    Dosage: 40 mg, unk
    Administration route: Oral
    Start date: 2011-08-10

Prednisolone
    Dosage: 10 mg, unk
    Administration route: Oral
    Start date: 2011-09-29

Prednisolone
    Dosage: 50 mg, unk
    Administration route: Oral
    Start date: 2011-07-30

Prednisolone
    Dosage: 60 mg, unk
    Administration route: Oral
    Indication: Glomerulonephritis Membranous
    Start date: 2011-07-05

Prednisolone
    Dosage: 50 mg, unk
    Administration route: Oral
    Start date: 2011-07-19
    End date: 2011-07-26

Other drugs received by patient: Baktar; Olmesartan Medoxomil; Alendronate Sodium; Famotidine; Carnaculin; Prednisolone; Prednisolone; Solu-Cortef; Prednisolone; Mecobalamin; Lipitor; Aspirin



Possible Neoral side effects in male

Reported by a physician from Japan on 2011-11-02

Patient: male, weighing 68.0 kg (149.6 pounds)

Reactions: Cerebral Small Vessel Ischaemic Disease, Malaise, Vision Blurred, Dizziness, Visual Acuity Reduced, Altered State of Consciousness, Convulsion, Loss of Consciousness

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Neoral
    Dosage: 125 mg, unk
    Administration route: Oral
    Indication: Glomerulonephritis Membranous
    Start date: 2011-08-03
    End date: 2011-08-15

Neoral
    Dosage: 50 mg, unk
    Administration route: Oral
    Start date: 2011-08-24
    End date: 2011-08-30

Prednisolone
    Dosage: 40 mg, unk
    Administration route: Oral
    Start date: 2011-08-10

Prednisolone
    Dosage: 7.5 mg, unk
    Administration route: Oral
    Start date: 2011-10-11

Prednisolone
    Dosage: 50 mg, unk
    Administration route: Oral
    Start date: 2011-07-19
    End date: 2011-07-26

Prednisolone
    Dosage: 50 mg, unk
    Administration route: Oral
    Start date: 2011-07-30

Prednisolone
    Dosage: 45 mg, unk
    Administration route: Oral
    Start date: 2011-08-03

Prednisolone
    Dosage: 10 mg, unk
    Administration route: Oral
    Start date: 2011-09-29

Prednisolone
    Dosage: 60 mg, unk
    Administration route: Oral
    Indication: Glomerulonephritis Membranous
    Start date: 2011-07-05

Prednisolone
    Dosage: 35 mg, unk
    Administration route: Oral
    Start date: 2011-08-17
    End date: 2011-08-30

Other drugs received by patient: Lipitor; Prednisolone; Carnaculin; Olmesartan Medoxomil; Prednisolone; Aspirin; Alendronate Sodium; Sulfamethoxazole; Prednisolone; Famotidine; Mecobalamin; Solu-Cortef



Possible Neoral side effects in male

Reported by a consumer/non-health professional from United States on 2011-10-31

Patient: male, weighing 112.0 kg (246.4 pounds)

Reactions: Weight Increased, Fatigue, Palpitations, Oedema Peripheral, Orthopnoea, Pulmonary Oedema, Blood Creatinine Increased, Cough, Cardiac Failure Congestive, Chest Discomfort, Dyspnoea, Pneumonia, Nausea, Coronary Artery Disease, Ascites, Hypertension, Blood Pressure Decreased

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Neoral

Other drugs received by patient: Amlodipine Besylate; Mycophenolate Mofetil (Cellcept); Mycophenolate Mofetil (Cellcept); Docusate Sodium; Exforge; Hydrocodone Bitartrate; Hydralazine HCL; Bumetanide; Acetaminophen; Omeprazole; Prilosec; Zaroxolyn; Calcium; BL Calcium; Ferrous Sulfate TAB; Humulin R; Aspirin; Isosorbide Mononitrate; Lipitor; Multivitamin; Prednisone; Terazosin HCL; Simvastatin; Calcium; Humulin N; Tylenol-500



Possible Neoral side effects in male

Reported by a physician from Japan on 2011-10-28

Patient: male

Reactions: Blood Bilirubin Increased, Multi-Organ Failure, Renal Impairment, Blood Lactate Dehydrogenase Increased, Viith Nerve Paralysis, Cardiac Failure Congestive, Herpes Zoster

Adverse event resulted in: death, hospitalization, disablity

Drug(s) suspected as cause:
Exjade
    Dosage: 500 mg, unk
    Administration route: Oral
    End date: 2009-08-25

Exjade
    Dosage: 500 mg, unk
    Administration route: Oral
    Indication: Iron Overload
    Start date: 2008-12-18

Exjade
    Dosage: 500 mg, qd
    Administration route: Oral
    Indication: Aplastic Anaemia
    Start date: 2008-06-18

Neoral
    Dosage: 100 mg/day
    Administration route: Oral
    Start date: 2008-11-19
    End date: 2010-05-08

Neoral
    Dosage: 150 mg, qd
    Administration route: Oral
    Indication: Aplastic Anaemia
    Start date: 2008-06-18
    End date: 2008-11-18

Other drugs received by patient: RED Blood Cells, Concentrated; RED Blood Cells, Concentrated; RED Blood Cells, Concentrated; Mucosta; RED Blood Cells, Concentrated; Platelets; RED Blood Cells, Concentrated; Solu-Cortef; RED Blood Cells, Concentrated; RED Blood Cells, Concentrated; Kalimate; Magnesium Oxide; RED Blood Cells, Concentrated; RED Blood Cells, Concentrated; Gran



Possible Neoral side effects in female

Reported by a physician from Japan on 2011-10-26

Patient: female, weighing 67.0 kg (147.4 pounds)

Reactions: Renal Tubular Disorder, Hydronephrosis, Nephropathy Toxic, Urine Output Decreased, Anuria, Ureteric Stenosis

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Acetaminophen
    Dosage: 4 df in total
    Administration route: Oral
    Start date: 2006-06-26
    End date: 2006-06-28

Mycophenolate Mofetil (Cellcept)
    Dosage: 1500 mg/ day
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2006-06-15

Neoral
    Dosage: 550 mg/ day, then tapered
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2006-06-22
    End date: 2006-07-10

Prednisolone
    Dosage: 50 mg/day, then tapered
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2006-06-15

Prograf
    Dosage: 10 mg / day, then tapered
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2006-06-16
    End date: 2006-06-21

Prograf
    Dosage: 4 mg/day
    Start date: 2006-07-11

Simulect
    Dosage: 20 mg daily
    Indication: Renal Transplant
    Start date: 2006-06-21
    End date: 2006-06-21

Simulect
    Dosage: 20 mg daily
    Start date: 2006-06-25
    End date: 2006-06-25

Other drugs received by patient: Solu-Medrol; Rabeprazole Sodium; Adalat



Possible Neoral side effects in male

Reported by a physician from Japan on 2011-10-24

Patient: male, weighing 60.0 kg (132.0 pounds)

Reactions: Abdominal Pain, Cholecystitis Acute, Oliguria, Pyrexia, Kidney Transplant Rejection

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Mycophenolate Mofetil (Cellcept)
    Start date: 2005-01-28
    End date: 2005-03-02

Neoral
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2005-01-30
    End date: 2005-03-09

Prednisolone
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2005-01-28

Simulect
    Dosage: 20 mg,
    Start date: 2005-01-31
    End date: 2005-02-01

Simulect
    Dosage: 20 mg,
    Indication: Renal Transplant
    Start date: 2005-01-28
    End date: 2005-01-28

Other drugs received by patient: Rabeprazole Sodium; Sandimmune; Solu-Medrol; Herbessor R; Sigmart



Possible Neoral side effects in male

Reported by a health professional (non-physician/pharmacist) from France on 2011-10-18

Patient: male, weighing 70.0 kg (154.0 pounds)

Reactions: Weight Increased, Lung Disorder, Oedema Peripheral, Cytomegalovirus Infection, Lymphoedema

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Certican
    Dosage: 0.75 mg, bid
    Indication: Heart Transplant
    Start date: 2009-06-01
    End date: 2011-01-17

Mycophenolate Mofetil (Cellcept)
    Dosage: 750 mg, bid
    Administration route: Oral
    Indication: Heart Transplant
    End date: 2011-01-17

Neoral
    Dosage: 30 mg, bid
    Indication: Heart Transplant

Other drugs received by patient: Pravastatin; Lasix; Nexium; Hyperium; Calcium Carbonate; Valproic Acid; Irinotecan HCL; Aspirin; Leucovorin Calcium; Prazepam; Fluorouracil

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012